Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
ADHD
Interventions
DIETARY_SUPPLEMENT

Eye Q

3 months of treatment with a polyunsaturated fatty acids or placebo. At 3 months a one-way treatment crossover of the placebo-group to active treatment was made so that both patient groups received active treatment for the remaining 3 month period.

Trial Locations (1)

00-576

Child and Adolescent Psychiatry Department, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT02114632 - Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter